Please Wait
Applying Filters...
menu
    • menu
    DMF filings rise 4.5% in Q3 2025; China holds lead, India records 20% growth in submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector October 2025: Novartis to buy Avidity for US$ 12 bn; FDA approves Bayer’s med to treat hot flashes

    Stock Recap
    #PipelineProspector

    Menu

    Silodosin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4,662Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    31/10/2025 Swati Spentose
    India
    		 Pharmapia Co., Ltd. Su258-20-ND Silodosin 2024-06-28 Swati Spentose Private Limited (Unit-I) India Plot No. A-1/2102 & 2103, Phase III, GIDC, VAPI - 396 195 Dist.- Valsad, Gujarat State India
    31/10/2025 Dongbang FTL
    South Korea
    		 Dongbang FTL Co., Ltd. 1731-11-ND Silodosin 2014-03-27 Dongbang FTL Co., Ltd. South Korea 78, Yakjakgongdan 4-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do